Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer.
- DOI
- 10.1038/s41391-025-00937-0
- Published
- 2026 Mar
- Container
- Prostate cancer and prostatic diseases
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41391-025-00937-0,
title = {Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer.},
author = {Ravi P and Xie W and Gillessen S and Tombal B and Spratt DE and Nguyen PL and Sweeney CJ},
year = {2026},
journal = {Prostate cancer and prostatic diseases},
doi = {10.1038/s41391-025-00937-0},
url = {https://doi.org/10.1038/s41391-025-00937-0}
}RIS
TY - JOUR TI - Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer. AU - Ravi P AU - Xie W AU - Gillessen S AU - Tombal B AU - Spratt DE AU - Nguyen PL AU - Sweeney CJ PY - 2026 JO - Prostate cancer and prostatic diseases DO - 10.1038/s41391-025-00937-0 UR - https://doi.org/10.1038/s41391-025-00937-0 ER -
APA
P, R., W, X., S, G., B, T., DE, S., PL, N., & CJ, S. (2026). Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer.. Prostate cancer and prostatic diseases. https://doi.org/10.1038/s41391-025-00937-0
Source records
- pubmed · retrieved 2026-09-26T12:08:59.179Z
- europe-pmc · retrieved 2026-09-26T12:08:59.176Z